Obinutuzumab vs. Ibrutinib in the Treatment of Treatment-Naïve Patients with Chronic Lymphocytic Leukemia —A Cost-Comparison Study in Colombia
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2577
https://www.valueinhealthjournal.com/article/S1098-3015(17)32911-X/fulltext
Title :
Obinutuzumab vs. Ibrutinib in the Treatment of Treatment-Naïve Patients with Chronic Lymphocytic Leukemia —A Cost-Comparison Study in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32911-X&doi=10.1016/j.jval.2017.08.2577
First page :
A875
Section Title :
SELECTED HEALTH CARE TREATMENT STUDIES -MEDICAL DEVICE/DIAGNOSTICS
Open access? :
No
Section Order :
2374